Intrinsic Value of S&P & Nasdaq Contact Us

ANI Pharmaceuticals, Inc. ANIP NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
70/100
3/7 Pass
SharesGrow Intrinsic Value
$482.01
+515.7%
Analyst Price Target
$107.00
+36.7%

Stock Statistics — ANIP

ANI Pharmaceuticals, Inc. (ANIP) has a market capitalization of $1.75B and trades at $78.29. The 52-week range is 56.71-99.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 22.4, Earnings Per Share (EPS) of $3.50, annual revenue of $883.37M.

The stock has a beta of 0.44, operates in the Healthcare sector.

Trading Data
Current Price$78.29
52-Week Range56.71-99.5
Volume195.33K
Avg Volume (30D)411.93K
Market Cap$1.75B
Beta (1Y)0.44
Company
IPO Date2000-05-05
Employees897
CEONikhil Lalwani
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS00182C1036
CUSIP00182C103
Income (Latest Year)
Revenue$883.37M
Gross Profit$450.64M
EBITDA$207.27M
Operating Income$81.23M
Net Income$78.34M
EPS$3.50
EPS Diluted$3.32
Shares Outstanding$20.05M
Balance Sheet (Latest Year)
Total Assets$1.44B
Current Assets$753.12M
Cash & ST Investments$285.59M
Total Liabilities$899.65M
Total Debt$325.2M
Net Debt$39.61M
Total Equity$540.72M
Debt / Equity0.60
Valuation Ratios
P/E Ratio22.4
P/S Ratio1.99
P/B Ratio3.25
EV/EBITDA (approx)8.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message